| Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Metabolism (NCT05047354) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2021-06-23 |
| Smith-Lemli-Opitz Syndrome and Cholic Acid (NCT03720990) | University of Nebraska | 2021-03-27 |
| Early Check: Expanded Screening in Newborns (NCT03655223) | RTI International | 2018-10-15 |
| Novel Treatment for Syndromic Ichthyoses (NCT01110642) | Northwestern University | 2011-07-01 |
| Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome (NCT01356420) | Oregon Health and Science University | 2011-01-01 |
| Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS) (NCT01773278) | University of Colorado, Denver | 2008-12-01 |
| Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome (NCT00114634) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2005-06-01 |
| Simvastatin Therapy in Smith-Lemli-Opitz Syndrome (NCT00064792) | Forbes Porter, M.D. | 2003-07-01 |
| Estimation of the Carrier Frequency and Incidence of Smith-Lemli-Opitz Syndrome in African Americans (NCT00017732) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2001-06-01 |
| Study of Smith-Lemli-Opitz Syndrome (NCT00001721) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1998-09-13 |
| Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome (NCT00272844) | Boston Children's Hospital | 1998-01-01 |